Format

Send to

Choose Destination
Clin Microbiol Infect. 2018 Feb;24(2):105-109. doi: 10.1016/j.cmi.2017.07.014. Epub 2017 Jul 24.

The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.

Author information

1
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen Macarena/Universidad de Sevilla/Centro Superior de Investigaciones Científicas (CSIC), Spain; Unidad Clínica de Farmacia Hospitalaria, Hospital Universitario Virgen Macarena, Seville, Spain.
2
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen Macarena/Universidad de Sevilla/Centro Superior de Investigaciones Científicas (CSIC), Spain.
3
Infectious Diseases, Internal Medicine 1, DZIF Center, Tübingen University Hospital, Tübingen, Germany.
4
Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
5
Paediatric Infectious Diseases Research Group, St George's University London, London, UK.
6
AstraZeneca LP, Gaithersburg, Maryland, USA.
7
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen Macarena/Universidad de Sevilla/Centro Superior de Investigaciones Científicas (CSIC), Spain. Electronic address: jesusrb@us.es.

Abstract

OBJECTIVES:

Surveillance is a key component of any control strategy for healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), and public availability of methodologic aspects is crucial for the interpretation of the data. We sought to systematically review publicly available information for HAIs and/or AMR surveillance systems organized by public institutions or scientific societies in European countries.

METHODS:

A systematic review of scientific and grey literature following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines was performed. Information on HAIs and/or AMR surveillance systems published until 31 October 2016 were included.

RESULTS:

A total of 112 surveillance systems were detected; 56 from 20 countries were finally included. Most exclusions were due to lack of publicly available information. Regarding AMR, the most frequent indicator was the proportion of resistant isolates (27 of 34 providing information, 79.42%); only 18 (52.9%) included incidence rates; the data were only laboratory based in 33 (78.5%) of the 42 providing this information. Regarding HAIs in intensive care units, all 22 of the systems providing data included central line-associated bloodstream infections, and 19 (86.3%) included ventilator-associated pneumonia and catheter-associated urinary tract infections; incidence density was the most frequent indicator. Regarding surgical site infections, the most frequent procedures included were hip prosthesis, colon surgery and caesarean section (21/22, 95.5%).

CONCLUSIONS:

Publicly available information about the methods and indicators of the surveillance system is frequently lacking. Despite the efforts of European Centre for Disease Control and Prevention (ECDC) and other organizations, wide heterogeneity in procedures and indicators still exists.

KEYWORDS:

Antimicrobial resistance; Epidemiology; Healthcare-associated infections; Surveillance; Systematic review

PMID:
28750921
DOI:
10.1016/j.cmi.2017.07.014
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center